Kenneth Erland Johnson insider trades
Open-market stock purchases and sales by Kenneth Erland Johnson, See Remarks at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Jun 25, 2018.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +107%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- XERS Xeris Biopharma Holdings, Inc: 1 buy, last Jan 31, 2025
Get free alerts when Kenneth Erland Johnson files a new trade →